---
title: "Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients"
date: "2025-01-24T09:55:35.000Z"
publishedDate: "24 janvier 2025"
summary: "Researchers from Mass General Brigham (Boston, USA) have evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation (AF) as part of the AZALEA-TIMI 71 study—reporting in the New England Journal of Medicine that the Factor XI inhibitor abelacimab (Anthos Therapeutics) significantly reduced bleeding compared to rivaroxaban, a [&#8230;] The post Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/factor-xi-inhibitor-lives-up-to-promise-of-reduced-bleeding-events-in-af-patients/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-01-24-factor-xi-inhibitor-lives-up-to-promise-of-reduced-bleeding-events-in-af-patients"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/01/generic-drugs-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/factor-xi-inhibitor-lives-up-to-promise-of-reduced-bleeding-events-in-af-patients/"
---

![Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/01/generic-drugs-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/factor-xi-inhibitor-lives-up-to-promise-of-reduced-bleeding-events-in-af-patients/*

## L’essentiel

Researchers from Mass General Brigham (Boston, USA) have evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation (AF) as part of the AZALEA-TIMI 71 study—reporting in the New England Journal of Medicine that the Factor XI inhibitor abelacimab (Anthos Therapeutics) significantly reduced bleeding compared to rivaroxaban, a [&#8230;] The post Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/factor-xi-inhibitor-lives-up-to-promise-of-reduced-bleeding-events-in-af-patients/
